Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open Label, Non-inferiority Study of Micafungin Versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients

NCT01058174 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01058174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01058174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open Label, Non-inferiority Study of Micafungin Versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
December 15, 2009
Completion date
May 3, 2012
Enrollment
350 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation, mycoses